CA1103161A - Traduction non-disponible - Google Patents

Traduction non-disponible

Info

Publication number
CA1103161A
CA1103161A CA276,537A CA276537A CA1103161A CA 1103161 A CA1103161 A CA 1103161A CA 276537 A CA276537 A CA 276537A CA 1103161 A CA1103161 A CA 1103161A
Authority
CA
Canada
Prior art keywords
therapeutic agent
composition according
carrier material
carrier
moisture content
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA276,537A
Other languages
English (en)
Inventor
Hans Lowey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Forest Laboratories LLC
Original Assignee
Forest Laboratories LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Forest Laboratories LLC filed Critical Forest Laboratories LLC
Application granted granted Critical
Publication of CA1103161A publication Critical patent/CA1103161A/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
CA276,537A 1976-05-05 1977-04-20 Traduction non-disponible Expired CA1103161A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68341076A 1976-05-05 1976-05-05
US683,410 1976-05-05

Publications (1)

Publication Number Publication Date
CA1103161A true CA1103161A (fr) 1981-06-16

Family

ID=24743943

Family Applications (1)

Application Number Title Priority Date Filing Date
CA276,537A Expired CA1103161A (fr) 1976-05-05 1977-04-20 Traduction non-disponible

Country Status (10)

Country Link
JP (1) JPS5817445B2 (fr)
BR (1) BR7702882A (fr)
CA (1) CA1103161A (fr)
DE (1) DE2718260C2 (fr)
FR (1) FR2358895A1 (fr)
GB (1) GB1583801A (fr)
IL (1) IL50175A0 (fr)
MX (1) MX4545E (fr)
SE (1) SE7704764L (fr)
YU (1) YU43437B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7919116B2 (en) 1998-03-20 2011-04-05 Andrx Labs, Llc Controlled release metformin formulations

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2042888B (en) * 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
JPS6034925B2 (ja) * 1979-07-31 1985-08-12 帝人株式会社 持続性鼻腔用製剤およびその製造法
US4259314A (en) 1979-12-10 1981-03-31 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
JPS59501162A (ja) * 1982-06-24 1984-07-05 キイ・フア−マシユ−テイカルズ・インコ−ポレイテツド 持続放出プロプラノロ−ル錠剤
JPS59193831A (ja) * 1983-04-18 1984-11-02 Sankyo Co Ltd 腸溶性製剤の製造法
US4680323A (en) * 1983-12-01 1987-07-14 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals for oral administration
US4775535A (en) * 1986-04-04 1988-10-04 Hans Lowey Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics
US4855143A (en) * 1986-04-04 1989-08-08 Hans Lowey Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics
ATE130189T1 (de) * 1989-08-25 1995-12-15 Bioglan Ireland R & D Ltd Pharmazeutische zusammensetzung und einnahmevorrichtung dafür.
JPH07112934A (ja) * 1993-10-15 1995-05-02 Taiyo Yakuhin Kogyo Kk ペントキシフィリンの徐放化製剤およびその製法
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3065143A (en) * 1960-04-19 1962-11-20 Richardson Merrell Inc Sustained release tablet
AU452221B2 (en) * 1971-09-20 1974-08-09 Forest Laboratories, Inc. Long-acting oral carrier
GB1388786A (en) * 1972-04-03 1975-03-26 Scherer Corp R P Integral solid gel-lattice dosage form of high-moisture content
US3965256A (en) * 1972-05-16 1976-06-22 Synergistics Slow release pharmaceutical compositions
GB1430684A (en) * 1972-06-26 1976-03-31 Lowey H Prolonged release lozenges

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7919116B2 (en) 1998-03-20 2011-04-05 Andrx Labs, Llc Controlled release metformin formulations
US8475841B2 (en) 1998-03-20 2013-07-02 Andrx Labs, Llc Controlled release metformin formulations

Also Published As

Publication number Publication date
DE2718260C2 (de) 1983-08-11
GB1583801A (en) 1981-02-04
MX4545E (es) 1982-06-10
FR2358895B1 (fr) 1982-10-22
SE7704764L (sv) 1977-11-06
YU184176A (en) 1984-02-29
DE2718260A1 (de) 1977-11-17
BR7702882A (pt) 1978-01-31
YU43437B (en) 1989-08-31
JPS5817445B2 (ja) 1983-04-07
JPS52145514A (en) 1977-12-03
FR2358895A1 (fr) 1978-02-17
IL50175A0 (en) 1976-09-30

Similar Documents

Publication Publication Date Title
US4226849A (en) Sustained release therapeutic compositions
US4357469A (en) Carrier base material for prolonged release therapeutic compositions
CA1103161A (fr) Traduction non-disponible
RU2142793C1 (ru) Твердая фармацевтическая композиция с регулируемым высвобождением лекарственного средства
US5211958A (en) Pharmaceutical composition and process for its preparation
CA2330480C (fr) Preparation a liberation controlee de divalproex sodium
JPS6212717A (ja) エリスロマイシン誘導体含有経口投与用固形医薬製剤及びその製造方法
DK173432B1 (da) Farmaceutisk kapsel med både hurtig og langvarig frigørelse til oral indgivelse af nitrofurantoin og fremgangsmåde til frem
US6419953B1 (en) Controlled release formulation of divalproex sodium
CA2501345A1 (fr) Forme gastro-retentive pour administrer du levodopa
PT1251832E (pt) Forma de dosagem constituída por invólucro-e-núcleo que conduz a uma libertação do fármaco de ordem zero
US4155993A (en) Prolonged-release pharmaceutical compositions for oral administration, their methods of making and use
US20080280981A1 (en) Tranexamic acid formulations
JP5000504B2 (ja) トラネキサム酸製剤
JPS62501845A (ja) 制御放出塩化カリウム
EP0181650A1 (fr) Comprimés dispersibles enrobés par compression
JP2004521890A (ja) 非吸湿性バルプロ酸ナトリウム組成物の製造方法
CN107095858B (zh) 一种熊去氧胆酸胶囊及其制备方法
HU221590B (hu) Béta-fenil-propiofenon-származékokat tartalmazó retard mikrotabletták
JP3061898B2 (ja) 固体の経口用イフォスファミド医薬組成物およびその製造法
RU2240784C1 (ru) Лекарственное средство на основе арбидола
JP2007509862A (ja) とりわけ（ｉ．ａ．）炭酸水素ナトリウムを含む、ナトリウムナプロキセンの非発泡形態
CN113274365A (zh) 雷美替胺速释缓释双释放制剂及其制备方法
RU2117488C1 (ru) Твердое инсулинсодержащее лекарственное средство
JP3646310B1 (ja) 経口投与用医薬組成物

Legal Events

Date Code Title Description
MKEX Expiry